Bristol-Myers Squibb
BMY
#167
Rank
A$171.33 B
Marketcap
A$84.13
Share price
-0.25%
Change (1 day)
-11.81%
Change (1 year)

EPS for Bristol-Myers Squibb (BMY)

EPS in 2025 (TTM): A$4.61

According to Bristol-Myers Squibb's latest financial reports the company's current EPS (TTM) is A$4.17. In 2024 the company made an earnings per share (EPS) of A-$6.20 a decrease over its 2023 EPS that were of A$5.44.

EPS history for Bristol-Myers Squibb from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A$4.61-174.35%
2024A-$6.20-213.92%
2023A$5.4430.2%
2022A$4.18-6.04%
2021A$4.45-179.29%
2020A-$5.61-281.37%
2019A$3.09-27.21%
2018A$4.25
2016A$3.75175.26%
2015A$1.36-19.83%
2014A$1.70-22.44%
2013A$2.1934.48%
2012A$1.63

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$15.62 275.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$10.32 147.81%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$1.91-54.21%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
A$3.36-19.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$32.29 675.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$20.10 382.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$2.90-30.47%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
A$15.42 270.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$10.25 146.02%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$7.50 80.13%๐Ÿ‡ฌ๐Ÿ‡ง UK